Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$13.54 - $15.35 $410,262 - $465,105
-30,300 Reduced 72.49%
11,500 $165,000
Q4 2021

Feb 15, 2022

BUY
$13.17 - $16.4 $59,265 - $73,800
4,500 Added 12.06%
41,800 $570,000
Q3 2021

Nov 16, 2021

BUY
$16.3 - $17.26 $9,780 - $10,356
600 Added 1.63%
37,300 $620,000
Q2 2021

Aug 16, 2021

SELL
$16.55 - $18.64 $1.05 Million - $1.19 Million
-63,600 Reduced 63.41%
36,700 $614,000
Q1 2021

May 18, 2021

BUY
$16.71 - $19.9 $1.43 Million - $1.7 Million
85,300 Added 568.67%
100,300 $1.81 Million
Q4 2020

Feb 17, 2021

BUY
$15.39 - $18.97 $230,850 - $284,550
15,000 New
15,000 $273,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.